Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Disease area: Airway diseases

Abstract

Introduction: The frequent exacerbator phenotype of COPD (fragile COPD) is associated with higher mortality, more exacerbations and greater resource consumption. A comprehensive care management program (CCMP) can be useful for the patient and the healthcare system.Objective: To evaluate the efficacy of a CCMP for patients with fragile COPD.Methods: Case-control study of patients with fragile COPD followed- up for at least 12 months. Cases were included in a CCMP consisting specialized medical evaluation, telephone and onsite monitoring by a case manager nurse and access to specialized care for early treatment of exacerbation. Controls received usual outpatient care. The number of admissions, emergency room (ER) visits, hospital days, number of treatments with steroids or antibiotics and survival rate were evaluated.Results: 36 cases and 36 controls matched for age and sex were studied. At baseline, cases had worse lung function and greater dyspnea than controls (FEV1 0.83 ± 0.26 vs 1.29 ± 0.54, p = 0.0001; mMRC 2.7 ± 0.88 vs 1.91 ± 0.85, p = 0.0018 respectively). However, during follow-up, cases had fewer hospital admissions (0.27 ± 0.57 vs 2.5 ± 1.96, p < 0.0001), fewer days of hospitalization (2.03 ± 4.64 vs 37.4 ± 35.9 , p < 0.0001) and required fewer trials of steroids and antibiotics than patients treated conventionally (1.1 ± 1.48 vs 2.9 ± 2.53, p = 0.0002; 1.4 ± 1.48 vs 3.1 ± 2.36, p = 0.0005, respectively) with no differences in mortality (11.8 vs 17.14 %, p = 0.70) or ER visits (0.21 ± 0.41 vs 0.66 ± 1.3, p = 0.325).Conclusion: A CCMP for fragile COPD patients is effective in the prevention of hospitalizations and reduction of moderate exacerbations compared to usual care.

Rating:

Share or cite this content

Citations should be made in the following way:
F. Fiorentino, V. Pardini, H. Shaffiek, R. Martinez, M. A. Noguera, J. L. Valera, E. Sala, B. G. Cosío (Palma de Mallorca, Spain; Alexandria, Egypt). Effectiveness of a comprehensive management program of fragile COPD patients. Eur Respir J 2014; 44: Suppl. 58, 1690

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations and healthcare resource utilization among COPD patients in Sweden Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Inhalation technique education and its impact in asthma and COPD Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Effectiveness of a comprehensive management program of fragile COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Integrated care reduces hospital utilization among patients with severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 COPD telemonitoring: Analysis of hospital admissions Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Frequency of COPD exacerbations in the real-life out-patient DACCORD cohort Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Effectiveness of self-treatment of exacerbations in COPD patients: Two-year follow-up of the COPE-II study Source: International Congress 2014 – Best abstracts in rehabilitation and chronic care (sponsored by MOTEK Medical) Year: 2014 Disease management program for COPD patients with frequent exacerbations Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Telehealthcare in COPD – A feasibility trial Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Frequency of COPD exacerbations and severity of COPD Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 The utility of remote cough monitoring in COPD Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013